Shaking Up Our Approach: The Need for Characterization and Optimization of Pre-clinical Models of Infant Abusive Head

Sydney Harris1, Holly R Chinnery2, Bridgette D Semple1,3,4

  • 1Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.

Journal of Neurotrauma
|March 18, 2024
PubMed

Insights

Abusive head trauma (AHT) is a severe infant injury. This review examines AHT diagnosis, pathology, and animal models, highlighting research gaps and treatment opportunities for better child development.

Area of Science:

  • Pediatric Neurology
  • Neuroscience
  • Public Health

Background:

  • Abusive head trauma (AHT) is a leading cause of death and disability in infants, often resulting from inflicted injuries by caregivers.
  • Repetitive AHT poses a significant burden, underscoring the need for better understanding and prevention strategies.

Purpose of the Study:

  • To review the clinical diagnosis, symptoms, prognosis, and neuropathology of AHT.
  • To evaluate existing animal models of AHT and define criteria for an ideal model.
  • To identify knowledge gaps and opportunities in pre-clinical AHT research and consider potential treatments.

Main Methods:

  • Literature review of clinical data, neuropathology, and existing animal models of AHT.
  • Comparative analysis of AHT with other injury models (e.g., repetitive mild TBIs, hypoxic-ischemic injuries).
  • Discussion of developmental milestones in vulnerable infants and potential therapeutic interventions.

Main Results:

  • AHT presents unique diagnostic and neuropathological challenges, particularly with repetitive injuries.
  • Current animal models have limitations in fully recapitulating the complexities of human AHT.
  • Insights from related injury models suggest avenues for future pre-clinical research.

Conclusions:

  • Optimized, well-characterized animal models are crucial for advancing AHT research.
  • Further investigation is needed to understand the long-term neuropathological and neurobehavioral consequences of AHT.
  • Developing effective treatments is essential to improve outcomes for affected children.